Corona Remedies IPO

Corona Remedies IPO is a book-built issue worth Rs 655.37 crores, consisting entirely of an Offer for Sale of 0.62 crore shares. The IPO will open for subscription on December 8, 2025, and close on December 10, 2025, with allotment expected on December 11, 2025, and listing on BSE and NSE scheduled for December 15, 2025. The price band is set at Rs 1,008–1,062 per share, and the lot size is 14 shares, requiring a minimum retail investment of Rs 14,868. The sNII investment stands at Rs 2,08,152, while bNII requires Rs 10,11,024. JM Financial Ltd. is the lead manager.

Corona Remedies IPO Details

Check out the issue details for Corona Remedies IPO as disclosed in SEBI.

Price Band

₹ 1008 - 1062

Issue Size

655.37 Cr.

Issue Type

Book Built

Open

2025-12-08

Close

2025-12-10

Corona Remedies News

 IPO news not found.

Company Financials

You can get the following financial statements of Corona Remedies as of now.

Corona Remedies IPO Details

The details about the Corona Remedies IPO are as follows:

  • The issue size of the IPO is Rs 655.37 Cr.
  • The price band for Corona Remedies IPO is Rs 1008 to Rs 1062..
  • The shares of Corona Remedies IPO will list on BSE and NSE.
  • The latest tentative GMP of Corona Remedies IPO is Rs .
  • The shares of Corona Remedies IPO are subscribed _ Times.

 

Corona Remedies IPO Valuation

The approximate valuation of Corona Remedies IPO based on its price band and RHP is:

Particulars Value
Upper Price Band Rs 1062
Existing Shares (Qty) 6.11 Cr
Market Cap Rs 6488.82 Cr
EPS (FY25) Rs 24.43
PE Ratio 43.47x
Industry PE 43.74x

 

Corona Remedies IPO Issue Size

Corona Remedies IPO issue size is Rs 655.37 Cr.

Issue Amount
Fresh Issue Rs 0 Cr
Offer For Sale Rs 655.37 Cr

 

Corona Remedies IPO Market Lot

An individual can apply for a minimum of 1 lot of 14 shares and a maximum of 13 lots (182 shares). Find the details below:

Application Lot Shares Amount
Retail Minimum 1 14 Rs 14,868
Retail Maximum 13 182 Rs 1,93,284

 

Corona Remedies IPO Share Offer

The shares of Corona Remedies IPO are subscribed _ Times. The category-wise shares offered are as follows:

Category % Offered
Qualified Institutional Not more than 50%
Non-Institutional Not less than 15%
Retail Individual Not less than 35%

 

Corona Remedies IPO GMP (Grey Market Premium)

As on GMP (Tentative)
3 December 2025 Rs

Corona Remedies IPO GMP is purely for informational purposes. Invest in an IPO after thoroughly researching on your own.

Corona Remedies IPO Dates

Find below the dates for Corona Remedies IPO

Schedule Date
Basis of Allotment 11 Dec 2025
Refunds 12 Dec 2025
Credit to Demat Account 12 Dec 2025
IPO Listing Date 15 Dec 2025

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales 576.16 617.33 884.05 1014.47
Total Expenditure 470.78 599.51 756.07 859.74
Operating Profit 105.39 17.82 127.98 154.74
Other Income 4.94 6.6 7.05 6.46
Interest 2.01 4.73 4.27 14.44
Depreciation 15.89 20.48 20.1 28.28
Exceptional Items 0 0 0 0
Profit Before Tax 92.43 -0.8 110.66 118.48
Provision for Tax 22.49 -0.4 25.96 27.98
Net Profit 69.95 -0.4 84.7 90.5
Adjusted EPS (Rs.) 1.37 -0.03 1.37 1.48

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2021 Mar 2022 Mar 2023 Mar 2024
Equity and Liabilities
Share Capital 5.03 51.05 61.55 61.55
Total Reserves 332.8 269.86 346.75 418.63
Borrowings 31.82 16.54 0 67
Other N/C liabilities 23.09 22.29 44.88 58.98
Current liabilities 191.47 193.92 209.26 268.81
Total Liabilities 584.21 553.65 662.43 874.96
Assets
Net Block 164.4 161.76 184.6 383.7
Capital WIP 0 14.23 64.71 120.59
Intangible WIP 0 0 0 0
Investments 7.06 7.07 25.3 25.31
Loans & Advances 1.18 4.21 9.54 8.56
Other N/C Assets 29 36.71 14.91 2.26
Current Assets 382.57 329.68 363.38 334.54
Total Assets 584.21 553.65 662.43 874.96
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2021 Mar 2022 Mar 2023 Mar 2024
Profit from operations 92.43 -0.8 110.66 118.48
Adjustment 28.87 20.34 22.78 46.87
Changes in Assets & Liabilities -14.53 79.66 -4.91 9.32
Tax Paid -27.61 -1.5 -25.82 -17.91
Operating Cash Flow 79.16 97.71 102.7 156.76
Investing Cash Flow -102.12 -65.81 -50.28 -266.64
Financing Cash Flow 0.09 -29.86 -44.75 98.54
Net Cash Flow -22.86 2.04 7.67 -11.34
X